These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1793454)

  • 1. Probucol, a superoxide free radical scavenger in vitro.
    Bridges AB; Scott NA; Belch JJ
    Atherosclerosis; 1991 Aug; 89(2-3):263-5. PubMed ID: 1793454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
    Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
    Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
    Ahmad F; Leake DS
    Chem Phys Lipids; 2018 Jul; 213():13-24. PubMed ID: 29518380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide: a general free radical scavenger.
    Scott NA; Jennings PE; Brown J; Belch JJ
    Eur J Pharmacol; 1991 Oct; 208(2):175-7. PubMed ID: 1800127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
    Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
    Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol as a potent inhibitor of oxygen radical-induced lipid peroxidation and DNA damage: in vitro studies.
    Iqbal M; Sharma SD; Okada S
    Redox Rep; 2004; 9(3):167-72. PubMed ID: 15327747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant activities of probucol against lipid peroxidations.
    Gotoh N; Shimizu K; Komuro E; Tsuchiya J; Noguchi N; Niki E
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):147-54. PubMed ID: 1329973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.
    Wu BJ; Kathir K; Witting PK; Beck K; Choy K; Li C; Croft KD; Mori TA; Tanous D; Adams MR; Lau AK; Stocker R
    J Exp Med; 2006 Apr; 203(4):1117-27. PubMed ID: 16606673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
    Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
    Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-ulcer effects of antioxidants: effect of probucol.
    Ito M; Suzuki Y; Ishihara M; Suzuki Y
    Eur J Pharmacol; 1998 Aug; 354(2-3):189-96. PubMed ID: 9754920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.
    Parthasarathy S
    J Clin Invest; 1992 May; 89(5):1618-21. PubMed ID: 1569200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidative properties of probucol estimated by the reactivity with superoxide and by electrochemical oxidation.
    Araki T; Kitaoka H
    Chem Pharm Bull (Tokyo); 2001 Aug; 49(8):943-7. PubMed ID: 11515582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases.
    Santanam N; Parthasarathy S
    J Clin Invest; 1995 Jun; 95(6):2594-600. PubMed ID: 7769102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
    Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
    Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I; Grundy SM
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
    Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
    Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
    Noguchi N; Gotoh N; Niki E
    Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of anti-atherogenic action of probucol].
    Ohya T; Egusa G
    Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.